![Alice Ly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alice Ly
Directeur/Membre du Conseil chez
Magnolia Neurosciences Corp.
Profil
Alice Ly is currently the Vice President at Alexandria Venture Investments LLC, a Board Observer at Twinstrand Biosciences, Inc., a Board Member at ApoGen Biotechnologies, Inc., the Site head at Alexandria Launchlabs, a Board Member at Proniras Corp., and a Board Member at Magnolia Neurosciences Corp.
Previously, she worked as an Associate Director at Yale University from 2010 to 2012 and as a Program Director at Harvard Innovation Labs from 2013 to 2018.
She also served as a Board Member at Rodeo Therapeutics Corp.
from 2020 to 2021.
Dr. Ly holds graduate and doctorate degrees from Yale University and an undergraduate degree from the University of California, Irvine.
Postes actifs de Alice Ly
| Sociétés | Poste | Début |
|---|---|---|
Alexandria Launchlabs
 Alexandria Launchlabs Internet Software/ServicesTechnology Services Operates as real estate platform for science laboratory offices | Corporate Officer/Principal | 01/01/2019 |
Alexandria Venture Investments LLC
 Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | 01/01/2022 |
Twinstrand Biosciences, Inc.
 Twinstrand Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomic technology and duplex sequencing technology to applications in clinical medicine & life sciences | Corporate Officer/Principal | 01/01/2019 |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Engages in research and development of drugs | Directeur/Membre du Conseil | 01/01/2020 |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 01/01/2020 |
Anciens postes connus de Alice Ly
| Sociétés | Poste | Fin |
|---|---|---|
Rodeo Therapeutics Corp.
 Rodeo Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develop novel molecules therapies | Directeur/Membre du Conseil | 31/12/2021 |
Harvard Innovation Labs
 Harvard Innovation Labs Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01/01/2018 |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Private Equity Investor | 01/01/2012 |
ApoGen Biotechnologies, Inc.
 ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company that focuses on the development of therapeutics targeting drivers of cancer genomic mutation | Directeur/Membre du Conseil | - |
Formation de Alice Ly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Finance |
Twinstrand Biosciences, Inc.
Twinstrand Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomic technology and duplex sequencing technology to applications in clinical medicine & life sciences | Commercial Services |
ApoGen Biotechnologies, Inc.
ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company that focuses on the development of therapeutics targeting drivers of cancer genomic mutation | Health Technology |
Alexandria Launchlabs
Alexandria Launchlabs Internet Software/ServicesTechnology Services Operates as real estate platform for science laboratory offices | Technology Services |
Rodeo Therapeutics Corp.
Rodeo Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develop novel molecules therapies | Health Technology |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Harvard Innovation Labs
Harvard Innovation Labs Investment ManagersFinance Acts as an alternative investment manager | Finance |
Magnolia Neurosciences Corp.
Magnolia Neurosciences Corp. BiotechnologyHealth Technology Engages in research and development of drugs | Health Technology |
